Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 29;17(1):594.
doi: 10.1186/s12879-017-2679-z.

Precisão e confiabilidade de um teste imuno-cromatográfico rápido NS1 para diagnóstico DENV-1 no ponto de atendimento e no laboratório

Affiliations

Precisão e confiabilidade de um teste imuno-cromatográfico rápido NS1 para diagnóstico DENV-1 no ponto de atendimento e no laboratório

Verónica Elizabeth Mata et al. BMC Infect Dis. .

Erratum in

Abstract

Background: Rapid immunochromatographic tests (ICT) for dengue non-structural protein 1 (NS1) have shown good performance for diagnosing acute-phase dengue in serum in laboratory settings, but rarely have been assessed in whole blood and at point of care (POC). This study compare the accuracy and inter- and intra-observer reliability of the NS1 Bioeasy™ ICT in whole blood at POC versus serum in the laboratory, during a DENV-1 epidemic.

Methods: Cross-sectional study involving 144 adults spontaneously demanding care in an emergency department within 4 days of onset of acute febrile illness. Accuracy of NS1 Bioeasy™ ICT was compared in whole blood and serum, both at 15 and 30 min, blinded to the reference RT-PCR or NS1 ELISA. Non-dengue patients were also tested for Zika virus with RT-PCR. Reliability of whole blood and serum readings by the same or different observers was measured by simple kappa (95% CI).

Results: At 15 min, sensitivity (Sn) of NS1 Bioeasy™ ICT in whole blood/POC was 76.7% (95% CI: 68.0-84.1) and specificity (Sp) was 87.0% (95% CI: 66.4-97.2). Sn in serum/laboratory was 82% (95% CI: 74.1-88.6) and Sp 100% (95% CI: 85.8-100). Positive likelihood ratio was 5.9 (95% CI: 2.0-17.0) for whole blood/POC and 19.8 (95% CI: 2.9-135.1) for serum/laboratory. Reliability of matched readings of whole blood/POC and serum/laboratory by the same observer (k = 0.83, 95% CI: 0.74-0.93) or different observers (k = 0.81, 95% CI: 0.72-0.92) was almost perfect, with higher discordant levels in the absence of dengue. Results did not differ statistically at 5%.

Conclusions: NS1 Bioeasy™ ICT in DENV-1 epidemics is a potentially confirmatory test. Invalid results at 15 min should be reread at 30 min. To optimize impact of implementing ICT in the management of false-negatives it should be incorporated into an algorithm according to setting and available specimen.

Trial registration: UTN U1111-1145-9451 .

Keywords: Dengue; Diagnosis; NS1; Point-of-care systems; Reproducibility of results; Sensitivity and specificity.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

O estudo foi aprovado pelo Conselho de Revisão Institucional do Instituto de Pesquisa Clínica Evandro Chagas (CAAE 0066.0.009.000-11). Todos os pacientes assinaram o formulário de consentimento livre e esclarecido.

Consentimento para publicação

Não aplicável.

Interesses competitivos

Os autores declaram que não têm interesses concorrentes.

Nota do editor

A Springer Nature permanece neutra em relação a reivindicações jurisdicionais em mapas publicados e afiliações institucionais.

Figures

Fig. 1
Fig. 1
Sample selection and laboratory analysis of 144 suspected dengue cases during a DENV-1 epidemic. a: rapid immunocromatographic test (index test), b: RT-PCR or ELISA NS1 positive (reference test)

Similar articles

Cited by

References

    1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: uma ameaça global contínua. Nat Rev Microbiol. 2010;8(12 Suppl):S7–16. doi: 10.1038/nrmicro2460. - DOI - PMC - PubMed
    1. Constenla D, Armien B, Arredondo J, Carabali M, Carrasquilla G, Castro R, et al. Custeio de casos de febre de dengue e surtos: recomendações de um grupo de trabalho de dengue de custo nas Américas. Valorar questões regionais de saúde. 2015;8C:80–91.
    1. Shepard DS, Undurradga EA, Halasa YA, Stanaway JD. O fardo econômico global da dengue: uma análise sistemática. Lancet Infect Dis. 2016;16(8):935–41. doi: 10.1016/S1473-3099(16)00146-8. - DOI - PubMed
    1. Organização Mundial da Saúde. Dengue - diretrizes para diagnóstico, tratamento, prevenção e controle. Genebra: OMS; 2009. p. 11. Disponível em: http://apps.who.int/iris/bitstream/10665/44188/1/9789241547871_eng.pdf. Accessed 9 Apr 2016
    1. Goodman C, Faulkner E, Gould C, Karnes E, Smith A, Aguiar C, et ai. O valor da inovação, adoção e difusão de diagnósticos nos cuidados de saúde. O grupo Lewin, inc. Adv Med. 2005; Disponível em: https://dx.advamed.org/sites/dx.advamed.org/files/resource/Lewin%20Value.... Acessado em 15 de dezembro de 2016

Publication types

MeSH terms

Substances